233 related articles for article (PubMed ID: 23510938)
1. SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.
Ju W; Li Q; Wilson SM; Brittain JM; Meroueh L; Khanna R
Channels (Austin); 2013; 7(3):153-9. PubMed ID: 23510938
[TBL] [Abstract][Full Text] [Related]
2. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
[TBL] [Abstract][Full Text] [Related]
4. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels.
François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R
Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699
[TBL] [Abstract][Full Text] [Related]
5. Non-SUMOylated CRMP2 decreases Na
Gomez K; Ran D; Madura CL; Moutal A; Khanna R
Mol Brain; 2021 Jan; 14(1):20. PubMed ID: 33478555
[TBL] [Abstract][Full Text] [Related]
6. Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic pain.
Moutal A; Cai S; Yu J; Stratton HJ; Chefdeville A; Gomez K; Ran D; Madura CL; Boinon L; Soto M; Zhou Y; Shan Z; Chew LA; Rodgers KE; Khanna R
Pain; 2020 Nov; 161(11):2629-2651. PubMed ID: 32569093
[TBL] [Abstract][Full Text] [Related]
7. A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.
Dustrude ET; Perez-Miller S; François-Moutal L; Moutal A; Khanna M; Khanna R
Channels (Austin); 2017 Jul; 11(4):316-328. PubMed ID: 28277940
[TBL] [Abstract][Full Text] [Related]
8. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons.
Cai S; Shan Z; Zhang Z; Moutal A; Khanna R
Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580
[TBL] [Abstract][Full Text] [Related]
9. Intranasal CRMP2-Ubc9 inhibitor regulates Na V 1.7 to alleviate trigeminal neuropathic pain.
Loya-Lopez SI; Allen HN; Duran P; Calderon-Rivera A; Gomez K; Kumar U; Shields R; Zeng R; Dwivedi A; Saurabh S; Korczeniewska OA; Khanna R
Pain; 2024 Mar; 165(3):573-588. PubMed ID: 37751532
[TBL] [Abstract][Full Text] [Related]
10. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.
Gomez K; Allen HN; Duran P; Loya-Lopez S; Calderon-Rivera A; Moutal A; Tang C; Nelson TS; Perez-Miller S; Khanna R
Pain; 2024 Apr; 165(4):866-883. PubMed ID: 37862053
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.
Dustrude ET; Moutal A; Yang X; Wang Y; Khanna M; Khanna R
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8443-E8452. PubMed ID: 27940916
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.
Wang L; Ji S
J Mol Neurosci; 2019 Nov; 69(3):391-398. PubMed ID: 31267313
[TBL] [Abstract][Full Text] [Related]
14. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
15. Ca
Silveirinha VC; Lin H; Tanifuji S; Mochida S; Cottrell GS; Cimarosti H; Stephens GJ
Cell Calcium; 2021 Jan; 93():102326. PubMed ID: 33360835
[TBL] [Abstract][Full Text] [Related]
16. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
[TBL] [Abstract][Full Text] [Related]
17. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
[TBL] [Abstract][Full Text] [Related]
19. TNF-α mediated upregulation of Na
de Macedo FHP; Aires RD; Fonseca EG; Ferreira RCM; Machado DPD; Chen L; Zhang FX; Souza IA; Lemos VS; Romero TRL; Moutal A; Khanna R; Zamponi GW; Cruz JS
Mol Brain; 2019 Dec; 12(1):117. PubMed ID: 31888677
[TBL] [Abstract][Full Text] [Related]
20. The impact of CRMP4 SUMOylation on the Cav1.2 interaction, neurite outgrowth and thermal pain sensitivity.
Lai S; Pan M; Liao H; Chen J; Jiang Y; Li Y
J Integr Neurosci; 2021 Sep; 20(3):595-603. PubMed ID: 34645092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
